Review ArticleReview
Current approaches in treatment of triple-negative breast cancer
Hanan Ahmed Wahba and Hend Ahmed El-Hadaad
Cancer Biology & Medicine June 2015, 12 (2) 106-116; DOI: https://doi.org/10.7497/j.issn.2095-3941.2015.0030
Hanan Ahmed Wahba
1Clinical Oncology and Nuclear Medicine, Mansoura University, Mansoura 35516, Egypt
Hend Ahmed El-Hadaad
1Clinical Oncology and Nuclear Medicine, Mansoura University, Mansoura 35516, Egypt
References
- 1.↵American Cancer Society. Cancer Facts and Figures 2010. Atlanta, Ga: American Cancer Society; 2010.
- 2.↵
- Brenton JD,
- Carey LA,
- Ahmed AA,
- Caldas C.
- 3.↵
- Anders CK,
- Carey LA.
- 4.↵
- Rakha EA,
- Reis-Filho JS,
- Ellis IO.
- 5.↵
- Crutcher CL,
- Cornwell LB,
- Chagpar AB.
- 6.↵
- 7.↵
- Dawood S.
- 8.↵
- Panoff JE,
- Hurley J,
- Takita C,
- Reis IM,
- Zhao W,
- Sujoy V, et al.
- 9.↵
- Abdulkarim BS,
- Cuartero J,
- Hanson J,
- Deschênes J,
- Lesniak D,
- Sabri S.
- 10.↵
- 11.↵
- 12.↵
- 13.↵
- Cardoso F,
- Senkus-Konefka E,
- Fallowfield L,
- Costa A,
- Castiglione M;
- 14.↵
- Gluz O,
- Liedtke C,
- Gottschalk N,
- Pusztai L,
- Nitz U,
- Harbeck N.
- 15.↵
- Slamon D,
- Mackey J,
- Robert N,
- Crown J,
- Martin M,
- Eiremann W, et al.
- 16.↵
- Gennari A,
- Sormani MP,
- Pronzato P,
- Puntoni M,
- Colozza M,
- Pfeffer U, et al.
- 17.↵
- Quinn JE,
- Kennedy RD,
- Mullan PB,
- Gilmore PM,
- Carty M,
- Johnston PG, et al.
- 18.↵
- Cleator S,
- Heller W,
- Coombes RC.
- 19.↵
- Geisler S,
- Lonning PE,
- Aas T,
- Johnsen H,
- Fluge O,
- Haugen DF, et al.
- 20.↵
- Lin NU,
- Claus E,
- Sohl J,
- Razzak AR,
- Arnaout A,
- Winer EP.
- 21.↵
- Kassam F,
- Enright K,
- Dent R,
- Dranitsaris G,
- Myers J,
- Flynn C, et al.
- 22.↵
- 23.↵
- Carey LA,
- Dees EC,
- Sawyer L,
- Gatti L,
- Moore DT,
- Collichio F, et al.
- 24.↵
- Le Tourneau C,
- Dettwiler S,
- Laurence V,
- Alran S,
- Beuzeboc P,
- Pierga JY, et al.
- 25.↵
- 26.↵
- Rastogi P,
- Anderson SJ,
- Bear HD,
- Geyer CE,
- Kahlenberg MS,
- Robidoux A, et al.
- 27.↵
- Rouzier R,
- Perou CM,
- Symmans WF,
- Ibrahim N,
- Cristofanilli M,
- Anderson K, et al.
- 28.↵
- Tassone P,
- Tagliaferri P,
- Perricelli A,
- Blotta S,
- Quaresima B,
- Martelli ML, et al.
- 29.↵
- Foulkes WD,
- Smith IE,
- Reis-Filho JS.
- 30.↵
- Bhattacharyya A,
- Ear US,
- Koller BH,
- Weichselbaum RR,
- Bishop DK.
- 31.↵
- 32.↵
- Ezzat AA,
- Ibrahim EM,
- Ajarim DS,
- Rahal MM,
- Raja MA,
- Tulbah AM, et al.
- 33.↵
- Frasci G,
- Comella P,
- Rinaldo M,
- Iodice G,
- Di Bonito M,
- D’Aiuto M, et al.
- 34.↵
- Bear HD,
- Tang G,
- Rastogi P,
- Geyer CE,
- Robidoux A,
- Atkins JN, et al.
- 35.↵
- Zelnak AB,
- Harichand-Herdt S,
- Styblo TM,
- Rizzo M,
- Gabram SG,
- Bumpers HL, et al.
- 36.↵
- Albain KS,
- Allred DC,
- Clark GM.
- 37.↵
- Gerber B,
- Loibl S,
- Eidtmann H,
- Rezai M,
- Fasching PA,
- Tesch H, et al.
- 38.↵
- 39.↵
- Goodin S.
- 40.↵
- Baselga J,
- Zambetti M,
- Llombart-Cussac A,
- Manikhas G,
- Kubista E,
- Steger GG, et al.
- 41.↵
- Dent R,
- Trudeau M,
- Pritchard KI,
- Hanna WM,
- Kahn HK,
- Sawka CA, et al.
- 42.↵
- 43.↵
- 44.↵
- Cheang M,
- Chia SK,
- Tu D,
- Jiang S,
- Shepherd LE,
- Pritchard KI, et al.
- 45.↵
- Henderson IC,
- Berry DA,
- Demetri GD,
- Cirrincione CT,
- Goldstein LJ,
- Martino S, et al.
- 46.↵
- Sparano JA,
- Wang M,
- Martino S,
- Jones V,
- Perez EA,
- Saphner T, et al.
- 47.↵
- 48.↵
- Rottenberg S,
- Nygren AO,
- Pajic M,
- van Leeuwen FW,
- van der Heijden I,
- van de Wetering K, et al.
- 49.↵
- Hugh J,
- Hanson J,
- Cheang MCU,
- Nielsen TO,
- Perou CM,
- Dumontet C, et al.
- 50.↵
- Muss HB,
- Berry DA,
- Cirrincione CT,
- Theodoulou M,
- Mauer AM,
- Kornblith AB, et al.
- 51.↵
- 52.↵
- Rugo HS,
- Roche H,
- Thomas E,
- Blackwell K,
- Chung H,
- Lerzo G, et al.
- 53.↵
- Biganzoli L,
- Cufer T,
- Bruning P,
- Coleman R,
- Duchateau L,
- Calvert AH, et al.
- 54.↵
- 55.↵
- Byrski T,
- Foszczynska-Kloda M,
- Huzarski T,
- Dent R,
- Gronwald J,
- Cybulski C, et al.
- 56.↵
- 57.↵
- O’Shaughnessy J,
- Miles D,
- Vukelja S,
- Moiseyenko V,
- Ayoub JP,
- Cervantes G, et al.
- 58.↵
- Martín M,
- Ruiz A,
- Muñoz M,
- Balil A,
- García-Mata J,
- Calvo L, et al.
- 59.↵
- Albain KS,
- Nag SM,
- Calderillo-Ruiz G,
- Jordaan JP,
- Llombart AC,
- Pluzanska A, et al.
- 60.↵
- Rottenberg S,
- Jaspers JE,
- Kersbergen A,
- van der Burg E,
- Nygren AO,
- Zander SA, et al.
- 61.↵
- Farmer H,
- McCabe N,
- Lord CJ,
- Tutt AN,
- Johnson DA,
- Richardson TB, et al.
- 62.↵
- O’Shaughnessy J,
- Osborne C,
- Pippen J,
- Yoffe M,
- Patt D,
- Monaghan G, et al.
- 63.↵
- Cepeda V,
- Fuertes MA,
- Castilla J,
- Alonso C,
- Quevedo C,
- Soto M, et al.
- 64.↵
- Miller K,
- Wang M,
- Gralow J,
- Dickler M,
- Cobleigh M,
- Perez EA, et al.
- 65.
- Miles D,
- Chan A,
- Romieu G,
- Dirix LY,
- Cortes J,
- Pivot X, et al.
- 66.↵
- Robert NJ,
- Dieras V,
- Glaspy J,
- Brufsky A,
- Bondarenko I,
- Lipatov O, et al.
- 67.↵
- Twelves C,
- Loesch D,
- Blum JL,
- Vahdat LT,
- Petrakova K,
- Chollet PJ, et al.
- 68.↵
- Desai N.
- 69.↵
- Ibrahim NK,
- Desai N,
- Legha S.
- 70.↵
- Gradishar WJ,
- Tjulandin S,
- Davidson N,
- Shaw H,
- Desai N,
- Bhar P, et al.
- 71.↵
- Lehmann BD,
- Bauer JA,
- Chen X,
- Sanders ME,
- Chakravarthy AB,
- Shyr Y, et al.
- 72.↵
- Beuvink I,
- Boulay A,
- Fumagalli S,
- Zilbermann F,
- Ruetz S,
- O’Reilly T, et al.
- 73.↵
- Cunningham D,
- Humblet Y,
- Siena S,
- Khayat D,
- Bleiberg H,
- Santoro A, et al.
- 74.↵
- Harding J,
- Burtness B.
- 75.↵
In this issue
Current approaches in treatment of triple-negative breast cancer
Hanan Ahmed Wahba, Hend Ahmed El-Hadaad
Cancer Biology & Medicine Jun 2015, 12 (2) 106-116; DOI: 10.7497/j.issn.2095-3941.2015.0030
Jump to section
Related Articles
- No related articles found.
Cited By...
- Crude extract of Ruellia tuberosa L. flower induces intracellular ROS, promotes DNA damage and apoptosis in Triple Negative Breast Cancer Cells
- A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer
- Inhibiting Fatty Acid Synthase with Omeprazole to Improve Efficacy of Neoadjuvant Chemotherapy in Patients with Operable TNBC
- Lipidome-based Targeting of STAT3-driven Breast Cancer Cells Using Poly-L-glutamic Acid-coated Layer-by-Layer Nanoparticles
- Profile of the breast cancer susceptibility marker rs4245739 identifies a role for miRNAs